ZANOSAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zanosar, and when can generic versions of Zanosar launch?
Zanosar is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in ZANOSAR is streptozocin. One supplier is listed for this compound. Additional details are available on the streptozocin profile page.
Summary for ZANOSAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 35 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZANOSAR |
What excipients (inactive ingredients) are in ZANOSAR? | ZANOSAR excipients list |
DailyMed Link: | ZANOSAR at DailyMed |
Pharmacology for ZANOSAR
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ZANOSAR
US Patents and Regulatory Information for ZANOSAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | ZANOSAR | streptozocin | INJECTABLE;INJECTION | 050577-001 | May 7, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |